These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Radio-frequency analysis of the effect of haloperidol and cyclo (leucyl-glycyl) on apomorphine-induced stereotypy. Fields JZ; Gonzalez LP; Meyerson LR; Lieber P; Lee JM; Steece KA; DeLeon-Jones FA; Ritzmann RF Pharmacol Biochem Behav; 1986 Dec; 25(6):1279-84. PubMed ID: 3809231 [TBL] [Abstract][Full Text] [Related]
5. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine. Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697 [TBL] [Abstract][Full Text] [Related]
6. Cyclo (Leu-Gly) + haloperidol: effects on dopamine receptors and conditioned avoidance responding. Bean AJ; Elgin RJ; Cooper DM; Martin GE Peptides; 1987; 8(1):39-44. PubMed ID: 3575153 [TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats. Bhargava HN Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116 [TBL] [Abstract][Full Text] [Related]
8. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding. Pierce RC; Rowlett JK; Bardo MT; Rebec GV Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684 [TBL] [Abstract][Full Text] [Related]
10. Cyclo(Leu-Gly) has opposite effects on D-2 dopamine receptors in different brain areas. Lee JM; Ritzmann RF; Fields JZ Peptides; 1984; 5(1):7-10. PubMed ID: 6231532 [TBL] [Abstract][Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
12. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat. Fields JZ; Gordon JH Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063 [TBL] [Abstract][Full Text] [Related]
13. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Prosser ES; Pruthi R; Csernansky JG Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596 [TBL] [Abstract][Full Text] [Related]
14. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol. Wolffgramm J; Rommelspacher H; Buck E Pharmacol Biochem Behav; 1990 Aug; 36(4):907-14. PubMed ID: 2217521 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG). Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK Peptides; 1987; 8(5):855-61. PubMed ID: 2893360 [TBL] [Abstract][Full Text] [Related]
16. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915 [TBL] [Abstract][Full Text] [Related]
17. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. Schröder U; Schröder H; Augustin W; Sabel BA J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425 [TBL] [Abstract][Full Text] [Related]
18. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity. Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363 [TBL] [Abstract][Full Text] [Related]
19. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states. LaHoste GJ; Wigal T; King BH; Schuck SEB; Crinella FM; Swanson JM Exp Clin Psychopharmacol; 2000 Feb; 8(1):125-132. PubMed ID: 10743913 [TBL] [Abstract][Full Text] [Related]
20. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats. Meller E Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]